Abstract
Multiple sclerosis (MS) is a common inflammatory disease of the central nervous system unsurpassed for its variability in disease outcome. As little is conclusively known about MS disease mechanisms, we have selected a variety of candidate genes that may influence the prognosis of the disease based on their function. A cohort of sporadic MS cases, taken from opposite extremes of the putative distribution of long-term outcome using the most stringent clinical criteria to date, was used to determine the role of on MS disease severity. The MS cases selected represent the prognostic best 5 % (benign MS) and worst 5 % (malignant MS) of cases in terms of clinical outcome assessed by the EDSS. Genotyping the two sets of MS patients (112 benign and 51 malignant) and a replication cohort from Sardinia provided no evidence to suggest that the genes selected have any outcome modifying activity, although small effects of these genes cannot be ruled out.
Similar content being viewed by others
References
The International Hapmap Consortium (2003) The International Hap-Map Project. Nature 426:789–796
Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265
Brassat D, Azais-Vuillemin C, Yaouanq J, Semana G, Reboul J, Cournu I, Mertens C, Edan G, Lyon-Caen O, Clanet M, Fontaine B (1999) Familial factors influence disability in MS multiplex families. French Multiple Sclerosis Genetics Group. Neurology 52:1632–1636
Bulman DE, Sadovnick AD, Ebers GC (1991) Age of onset in siblings concordant for multiple sclerosis. Brain 114(Pt 2):937–950
Chataway J, Mander A, Robertson N, Sawcer S, Deans J, Fraser M, Broadley S, Clayton D, Compston A (2001) Multiple sclerosis in sibling pairs: an analysis of 250 families. J Neurol Neurosurg Psychiatry 71:757–761
Davie CA, Barker GJ, Webb S, Tofts PS, Thompson AJ, Harding AE, McDonald WI, Miller DH (1995) Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 118(Pt 6):1583–1592
Deluca GC, Ramagopalan SV, Cader MZ, Dyment DA, Herrera BM, Orton S, Degenhardt A, Pugliatti M, Sadovnick AD, Sotgiu S, Ebers GC (2007) The role of hereditary spastic paraplegia related genes in multiple sclerosis : A study of disease susceptibility and clinical outcome. J Neurol 254:1221–1226
Deluca GC, Ramagopalan SV, Herrera BM, Dyment DA, Lincoln MR, Montpetit A, Pugliatti M, Bernardo MC, Risch NJ, Sadovnick AD, Chao M, Sotgiu S, Hudson TJ, Ebers GC (2007) An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLYDRBI locus. Proc Natl Acad Sci USA 104:20896–20901
Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225–2229
Hensiek AE, Seaman SR, Barcellos LF, Oturai A, Eraksoi M, Cocco E, Vecsei L, Stewart G, Dubois B, Bellman-Strobl J, Leone M, Andersen O, Bencsik K, Booth D, Celius EG, Harbo HF, Hauser SL, Heard R, Hillert J, Myhr KM, Marrosu MG, Oksenberg JR, Rajda C, Sawcer SJ, Sorensen PS, Zipp F, Compston DA (2007) Familial effects on the clinical course of multiple sclerosis. Neurology 68:376–383
Iannucci G, Minicucci L, Rodegher M, Sormani MP, Comi G, Filippi M (1999) Correlations between clinical and MRI involvement in multiple sclerosis: assessment using T(1), T(2) and MT histograms. Journal of the Neurological Sciences 171:121–129
Lassmann H (1998) Neuropathology in multiple sclerosis: new concepts. Multiple Sclerosis 4:93–98
McAlpine D, Lumsden CE, Acheson ED (1972) Multiple sclerosis: a reappraisal. Churchill Livingstone, Edinburgh
Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938–952
Nyholt DR (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74:765–769
Olerup O, Zetterquist H (1992) HLADR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39:225–235
Purcell S, Cherny SS, Sham PC (2003) Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149–150
Ramagopalan SV, Deluca GC, Morrison KM, Herrera BM, Dyment DA, Orton S, Bihoreau MT, Degenhardt A, Pugliatti M, Sadovnick AD, Sotgiu S, Ebers GC (2007) No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis. J Neuroimmunol 186:156–160
Ramagopalan SV, Dyment DA, Valdar W, Herrera BM, Criscuoli M, Yee IM, Sadovnick AD, Ebers GC (2007) Autoimmune disease in families with multiple sclerosis: a population-based study. Lancet Neurol 6:604–610
Ramagopalan SV, Morris AP, Dyment DA, Herrera BM, Deluca GC, Lincoln MR, Orton SM, Chao MJ, Sadovnick AD, Ebers GC (2007) The inheritance of resistance alleles in multiple sclerosis. PLoS Genet 3:e150
Risch N, Zhang H (1995) Extreme discordant sib pairs for mapping quantitative trait loci in humans. Science 268:1584–1589
Robertson NP, Clayton D, Fraser M, Deans J, Compston DA (1996) Clinical concordance in sibling pairs with multiple sclerosis. Neurology 47:347–352
Runmarker B, Andersen O (1993) Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 116(Pt 1):117–134
Sadovnick AD, Risch NJ, Ebers GC (1998) Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Canadian Collaborative Study Group. Can J Neurol Sci 25:216–221
Willer CJ, Dyment DA, Risch NJ, Sadovnick AD, Ebers GC (2003) Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci USA 100:12877–12882
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ramagopalan, S.V., DeLuca, G.C., Morrison, K.M. et al. Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis. J Neurol 255, 1215–1219 (2008). https://doi.org/10.1007/s00415-008-0878-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-008-0878-7